Tenderwize
Retour à la recherche

Динамична система за покупки на лекарствени продукти за нуждите на лечебното заведение

МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ СВ. ИВАН РИЛСКИ ГОРНА ОРЯХОВИЦА ЕООД·гр. Горна Оряховица, Bulgaria·BGN 2M·Deadline Sep 10, 2027 · 377 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Bulgaria – Pharmaceutical products – Динамична система за покупки на лекарствени продукти за нуждите на лечебното заведение

70/100

Score d'opportunité

PromisingLow complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

70 / 100

Complexité

30 / 100

Facteurs de risque

Structured data shows a deadline of 2027-09-10 (DPS end), while the description states initial application deadline is...

Suppliers must hold specific Bulgarian or EU wholesale authorization and may need narcotics license. Foreign suppliers...

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Strong opportunity

Faits clés

  • BGN 2M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Delivery of pharmaceutical products for MBAL Sv. Ivan Rilski Gorna Oryahovitsa
  • Products include those from the Positive Drug List and others
Afficher le résumé complet

DPS for pharmaceutical products supply for MBAL Sv. Ivan Rilski Gorna Oryahovitsa, Bulgaria. Estimated value 2,047,628 BGN, 36-month duration, open to all qualified suppliers. Award criteria: lowest price. Initial application deadline 2024-10-11, but structured data shows DPS end date 2027-09-10.

Risques

Structured data shows a deadline of 2027-09-10 (DPS end), while the description states initial application deadline is...

Suppliers must hold specific Bulgarian or EU wholesale authorization and may need narcotics license. Foreign suppliers...

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must be registered as a wholesaler under Bulgarian or EU/EEA law
  • Must hold a valid wholesale authorization for medicinal products (or equivalent from another Member State)
  • Must be registered in the Register of wholesalers at the Bulgarian Drug Agency (IAL)

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Най-ниска цена

Acheteur

Localisation

гр. Горна Оряховица, BGR

Site web

mbalgo.com/

Profil acheteur

Ouvrir le profil

Identifiant

104512579

Activité

Health

Lots (1)

LOT-0001

Динамична система за покупки на лекарствени продукти за нуждите на лечебното заведение

Supply of pharmaceutical products (both from Positive Drug List and outside) for the hospital. Estimated quantities are indicative and subject to change. The DPS is open for 36 months.

SuppliesDPSEU fundedElectronic submission

BGN 2M

Valeur estimée

Localisation

Горна Оряховица, Bulgaria

Durée

Oct 2024

Catégorie

Pharmaceutical products

Critères d'attribution

Най-ниска цена

Date limite

Deadline Sep 10, 2027

Détails de la procédure

Date de publication
10 Sep 2024
Langues
Bulgarian

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
544857-2024

Documents (1)

Document de consultation 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30